Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Bioverativ, a Sanofi company · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
cold agglutinin disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909569
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.